HSA Deepens Local and Global Collaboration to Accelerate Health Innovation
HSA announced deepened regulatory collaboration at the 2026 Health Regulation Conference.
Singapore is ASEAN's most mature and international regulatory hub market. HSA manages Classes A–D and offers Immediate/Abridged/Full/Expedited evaluation routes based on reference-country approvals; registrations remain valid long term with annual renewal.
Classify per GN-13; choose Immediate/Abridged/Full routes
Appoint the Singapore-based Registrant
Submit via the SHARE system and pay fees
Respond to HSA evaluation queries
Listed in the SMDR; fulfil annual renewal and vigilance obligations
| Product Class | Timeline | Notes |
|---|---|---|
| Class A | ~90 working days | Registration (SHARE system) |
| Class B | ~100 working days | Standard evaluation; mature products may use Immediate |
| Classes C / D | ~180 working days | In-depth evaluation; multiple reference-country approvals may use Expedited |
Regulatory Updates
HSA announced deepened regulatory collaboration at the 2026 Health Regulation Conference.
The annual window runs to 31 December; eligible devices receive fee waivers.
Registration, evaluation and annual maintenance fees updated — adjust budgets accordingly.
Clarifying algorithm changes, PCCP and post-market monitoring requirements.
Electronic submission keeps improving — check the website for acceptance arrangements during switchover.
E-commerce devices must be registered or legally supplied via special channels.
Focus on consistency between local-language labels, IFU and approved registration information.
Integrated online/offline sweeps — purchasers must verify registration numbers and status.
Registrants must assess and notify field safety corrective actions promptly.
Registration holders must maintain a PMS system and submit AE and periodic reports on time.
Judgement criteria for new categories (software, combination products) further clarified.
Major changes require prior approval; notifiable changes must be submitted within deadlines.
Registration certificates, authorization chains and importer qualifications are port-check priorities.
Products with MDA registrations use the simplified route with visibly shorter timelines.
Foreign manufacturers must complete registration and post-market duties via local representatives.
Sessions on registration procedures and common rejection reasons for companies and local representatives.
Updated fees for registration, evaluation and annual renewal.
Leveraging ASEAN ACCS/GHWP mechanisms, regional review alignment keeps deepening.
Phased product-traceability coding — exporters should watch data-reporting requirements.
Full rollout of the SHARE electronic platform — one-stop online registration.
Renewals take time — prepare and submit 6–12 months in advance.
Device, therapeutic product and cell/tissue/gene therapy functions consolidated under HSA.
Consistency between certificate scope and actual production sites is the audit priority.
Tracking global regulatory harmonization as local rules keep aligning internationally.
Claims must match the approved intended use; violations face penalties.
Recall information for specific models/batches — cross-check your on-sale products.
Affected products need supplementary verification or test reports per new versions.
Classification and life-cycle requirements for AI and software products keep evolving.
Bidding requires valid registration certificates and supply qualifications matching registration data.
LOAs, FSCs and similar documents must be legalized before acceptance.
* Sources: official website and announcements of Health Sciences Authority (HSA) (Singapore HSA Register SMDR). Click “Official source” to verify.
Case Studies
27 cases in total; for the full list see the Case Studies Overview and filter by Singapore.
Contact Us
Delivered directly by our local team, registrations held by the manufacturer. Get a free initial access assessment.